#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antiphospholipid syndrome Subdural haematoma Metachromatic leukodystrophy Osteogenesis imperfecta Ovarian cancer Systemic lupus erythematosus Chronic hepatitis B Granulomatosis with polyangiitis Immune-mediated enterocolitis Spinal cord injury Polyneuropathy Pulmonary fibrosis Fms-like tyrosine kinase 3 positive Urethral valves Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Life with Disease Haemophilia Hepatoblastoma – Trials in Disease Mantle cell lymphoma stage III – Basic Information Angiosarcoma – Treatment Andersen-Tawil syndrome – Basic Information Skin angiosarcoma – Basic Information Alternating hemiplegia of childhood – Life with Disease Stevens-Johnson syndrome – Life with Disease Von Willebrand’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CLESROVIMAB Alnus Glutinosa Pollen Dimethyl Fumarate Annamycin Tisotumab Vedotin Lifileucel Platelet Concentrate VG801-2 Metyrapone Brodalumab Amoxicillin Sodium Mocravimod Dabigatran Evolocumab Tipiracil Hydrochloride Ibutamoren Mesilate Doxycycline Hyclate Erenumab Mbf-015 ALE.P02 More therapies…

    Learn about Your Condition

    Carotid artery stenosis Substance use disorder Device related infection Appendicitis Cervical dysplasia Peripheral artery angioplasty Paget's disease of the vulva Dermatitis Chronic hepatitis C Peripheral artery restenosis Eye inflammation IgA nephropathy Colon cancer stage II Hyperhidrosis Cardiac failure congestive More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU De Rouen

CHU De Rouen

147 Avenue Du Marechal Juin, Bois-Guillaume, 76230, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Preventing Rejection in Kidney Transplant Patients Using Rabbit Anti-Human Thymocyte Immunoglobulin and Basiliximab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Basiliximab
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Study on the Effectiveness of Ceftriaxone and Metronidazole Combination for Patients with Hurley Stage 2 Hidradenitis Suppurativa

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Ceftriaxone
    • Lidocaine Hydrochloride
    • Lymecycline
    France

  • Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Imlifidase
    • Loratadine
    Austria Belgium Czechia Denmark France Germany +6

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!